Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 3.1 Form of Second Amended and Restated Memorandum and Articles of Association (to Be Effective In Connection with the Completion of This Offering)
- 4.1 Specimen Certificate Evidencing Class a Ordinary Shares
- 4.2 Form of Underwriters' Warrant
- 5.1 Opinion of Ogier
- 5.2 Opinion of Loeb & Loeb LLP
- 5.3 Opinion of Wong Tan & Molly Lim LLC Regarding Certain Singapore Law Matters
- 10.1 Office Agreement Between Virax Biolabs LTD and the Argyll Club LTD, Dated September 6, 2021
- 10.2 Secretarial Service and Office Agreement Between Shanghai Biotechnology Devices Limited and Flexkin Corporate Services Limited, Dated April 26, 2021
- 10.3 Share Exchange Agreement Between Virax Biolabs (Cayman) Limited, Virax Biolabs (Uk) Limited, Virax Biolabs Limited and Selling Shareholders, Dated September 20, 2021
- 10.4 Exclusive Distribution Agreement Between Nanjing Vazyme Medical Technology Co. LTD and Virax Biolabs Limited, Dated August 4, 2021
- 10.5 Form of Employment Agreement by and Between the Registrant and Its Directors and Officers
- 10.6 Form of Independent Director Agreement by and Between the Registrant and Certain of Its Independent Directors
- 10.7 2022 Equity Incentive Plan
- 21.1 List of Subsidiaries
- 23.1 Consent of BF Borgers Cpa PC, an Independent Registered Public Accounting Firm
- 99.1 Code of Business Conduct and Ethics
- EX-FILING FEES Filing Fee Table
Associated filings
- 21 Jul 22 424B4 Prospectus supplement with pricing info
- 1 Jul 22 EFFECT Notice of effectiveness
- 30 Jun 22 FWP Free writing prospectus
- 30 Jun 22 FWP Free writing prospectus
- 24 Jun 22 F-1/A Registration statement (foreign) (amended)
- 24 Jun 22 F-1/A Registration statement (foreign) (amended)
- 21 Jun 22 F-1/A Registration statement (foreign) (amended)
- 6 Jun 22 F-1/A Registration statement (foreign) (amended)
- 11 May 22 F-1/A Registration statement (foreign) (amended)
- 22 Apr 22 F-1/A Registration statement (foreign) (amended)
-
18 Mar 22 F-1 Registration statement (foreign)
VRAX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors of
Virax Biolabs Group Limited
We consent to the inclusion in the Form F-1 Registration Statement of Virax Biolabs Group Limited our report dated December 27, 2021 relating to our audit of the statements of financial position as of march 31, 2021 and 2020 and statements of comprehensive loss, changes in shareholders’ equity (deficit) and cash flows for the years ended March 31, 2021 and 2020.
We also consent to the reference to us under the caption “Experts” in the Registration Statement.
/s/ BF Borgers CPA PC
Certified Public Accountants
Lakewood, Colorado
March 18, 2022